Unique stem cell lines identifier	1. SCVIi049-A
	2. SCVIi050-A
Alternative name(s) of stem cell lines	1. SCVIi049-A / SCVI104
	2. SCVIi050-A / SCVI2486
Institution	Stanford Cardiovascular Institute, Stanford, CA, US
Contact information of distributor	Joseph C. Wu, joewu@stanford.edu
Type of cell lines	iPSC
Origin	Human
Additional origin info required for human ESC or iPSC	Age: 44 (SCVIi049-A) and 30 (SCVIi050-A)
	Sex: male
	Ethnicity if known: Not Hispanic or Latino
Cell Source	Fibroblast (SCVIi049-A), PBMC (SCVIi050-A)
Clonality	Clonal
Method of reprogramming	Nonintegrating Sendai virus expression of human OCT4, SOX2, KLF4, and c-MYC
Genetic Modification	Yes
Type of Genetic Modification	Spontaneous mutation
Evidence of the reprogramming transgene loss (including genomic copy if applicable)	RT-qPCR
Associated disease	Dilated cardiomyopathy (DCM)
Gene/locus	PLN (6q22.31)
	SCVIi049-A: heterozygous PLN (c.25C > T)
	SCVIi050-A: heterozygous PLN (c.40_42delAGA)
Date archived/stock date	SCVIi049-A: 09/10/2019
	SCVIi050-A: 12/03/2021
Cell line repository/bank	https://hpscreg.eu/cell-line/SCVIi049-A
	https://hpscreg.eu/cell-line/SCVIi050-A
Ethical approval	The generation of the lines was approved by the Administrative Panel of Human Subjects Research (IRB) under IRB #29904 “Derivation of Human Induced Pluripotent Stem Cells”